Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database

Verfasser / Beitragende:
[Tomohisa Furuhata, Kenji Okita, Toshihiko Nishidate, Koichi Hirata, Hirofumi Ohnishi, Hirotoshi Kobayashi, Kenjiro Kotake, Kenichi Sugihara]
Ort, Verlag, Jahr:
2015
Enthalten in:
International Journal of Clinical Oncology, 20/5(2015-10-01), 922-927
Format:
Artikel (online)
ID: 605491631
LEADER caa a22 4500
001 605491631
003 CHVBK
005 20210128100511.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s10147-015-0815-6  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10147-015-0815-6 
245 0 0 |a Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database  |h [Elektronische Daten]  |c [Tomohisa Furuhata, Kenji Okita, Toshihiko Nishidate, Koichi Hirata, Hirofumi Ohnishi, Hirotoshi Kobayashi, Kenjiro Kotake, Kenichi Sugihara] 
520 3 |a Background: Peritoneal metastasis is recognized as a predictor of poor prognosis in patients with colorectal cancer, and whether surgical intervention for peritoneal metastasis has any clinical benefit has remained controversial. The purposes of this study were to identify prognostic factors in cases of unresectable colorectal cancer with synchronous peritoneal metastasis and to clarify the impacts of primary tumor resection with high tie lymph node dissection. Methods: A multi-institutional retrospective analysis was conducted of 579 patients who underwent resection of the primary tumor for unresectable colorectal cancer with peritoneal metastasis between 1991 and 2007. For these 579 patients, clinicopathological variables were analyzed for prognostic significance using Cox proportional hazards model and propensity score analysis to mitigate the selection bias. Results: Multivariate analysis revealed hematogenous metastasis (p<0.001), histology of the tumor (p=0.006), postoperative chemotherapy (p<0.001), and lymph node dissection (p=0.001) as independent prognostic factors. In the propensity-matched cohort, patients treated with high tie lymph node dissection showed a significantly better overall survival than those with low tie lymph node dissection (median overall survival 13.0 vs. 11.5months; p=0.041). Conclusions: It is suggested that primary tumor resection with high tie lymph node dissection favorably affects survival, even in unresectable colorectal cancer with peritoneal metastasis. 
540 |a Japan Society of Clinical Oncology, 2015 
690 7 |a Colorectal cancer  |2 nationallicence 
690 7 |a Peritoneal metastasis  |2 nationallicence 
690 7 |a Lymph node dissection  |2 nationallicence 
690 7 |a Propensity score analysis  |2 nationallicence 
700 1 |a Furuhata  |D Tomohisa  |u Department of Nursing, Sapporo Medical University, South 1, West 17, Chuo-ku, Sapporo, Japan  |4 aut 
700 1 |a Okita  |D Kenji  |u Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan  |4 aut 
700 1 |a Nishidate  |D Toshihiko  |u Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan  |4 aut 
700 1 |a Hirata  |D Koichi  |u Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan  |4 aut 
700 1 |a Ohnishi  |D Hirofumi  |u Department of Public Health, Sapporo Medical University, Sapporo, Japan  |4 aut 
700 1 |a Kobayashi  |D Hirotoshi  |u Department of Surgical Oncology, Tokyo Medical and Dental University, Tokyo, Japan  |4 aut 
700 1 |a Kotake  |D Kenjiro  |u Department of Surgery, Tochigi Cancer Center, Utsunomiya, Japan  |4 aut 
700 1 |a Sugihara  |D Kenichi  |u Department of Surgical Oncology, Tokyo Medical and Dental University, Tokyo, Japan  |4 aut 
773 0 |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/5(2015-10-01), 922-927  |x 1341-9625  |q 20:5<922  |1 2015  |2 20  |o 10147 
856 4 0 |u https://doi.org/10.1007/s10147-015-0815-6  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10147-015-0815-6  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Furuhata  |D Tomohisa  |u Department of Nursing, Sapporo Medical University, South 1, West 17, Chuo-ku, Sapporo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Okita  |D Kenji  |u Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nishidate  |D Toshihiko  |u Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Hirata  |D Koichi  |u Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ohnishi  |D Hirofumi  |u Department of Public Health, Sapporo Medical University, Sapporo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kobayashi  |D Hirotoshi  |u Department of Surgical Oncology, Tokyo Medical and Dental University, Tokyo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kotake  |D Kenjiro  |u Department of Surgery, Tochigi Cancer Center, Utsunomiya, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sugihara  |D Kenichi  |u Department of Surgical Oncology, Tokyo Medical and Dental University, Tokyo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/5(2015-10-01), 922-927  |x 1341-9625  |q 20:5<922  |1 2015  |2 20  |o 10147